関連する実験動画
Updated: Nov 16, 2025

10:30
Visualization of IL-22-expressing Lymphocytes Using Reporter Mice
Published on: January 25, 2017
9.1K
IL-12とIL-23受容体共有の構造的基礎は,T対NK細胞の作用を形作るためのゲートウェイを明らかにする
Caleb R Glassman1, Yamuna Kalyani Mathiharan2, Kevin M Jude3
1Program in Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Cell
|February 19, 2021
まとめ
研究者は,NK細胞を節約しながら,選択的にCD8+T細胞を活性化する新しいIL-12部分的アゴニストを設計しました. これらの標的治療は,毒性が低下した抗腫瘍免疫の有望性を示しています.
科学分野:
- 免疫学
- 構造生物学
- 生物化学
背景:
- リンパ球の反応を調節する重要なサイトカインであるインタールイキン-12 (IL-12) とインタールイキン-23 (IL-23).
- 両方のサイトカインは,信号伝達のためにIL-12受容体β1 (IL-12Rβ1) のサブユニットを共有しています.
- 彼らの受容体相互作用を理解することは 治療開発の鍵です
研究 の 目的:
- IL-12とIL-23の受容体共有の構造的基礎を解明する.
- 改善された安全性と有効性のプロファイルを持つ新しいIL-12ベースの治療法を設計する.
- 共有されたIL-12Rβ1/p40インターフェースをターゲットにする機能的影響を調査する.
主な方法:
- IL-23受容体の結晶構造の決定
- IL-12およびIL-23受容体複合体の冷凍電子顕微鏡 (冷凍EM)
- IL-12 部分アゴニストの設計と in vitro/in vivo 試験
主要な成果:
- IL-12とIL-23受容体複合体の非正規のトポロジーを明らかにし,IL-12Rβ1がp40サブユニットと直接関わっていることを強調した.
- CD8+ T細胞によるIFNγ誘導を保ち,NK細胞のサイトカイン生成を減少させるIL-12部分アゴニストを開発した.
- これらの部分的アゴニストは,NK細胞媒介による毒性なしに,体内でMC-38腺がんに対する抗腫瘍免疫を誘発することを実証した.
結論:
- IL-12ファミリーのサイトカインによる受容体共有の構造的メカニズムは,タンパク質インターフェースエンジニアリングの青写真を提供します.
- 共有されたIL-12Rβ1/ p40インターフェースをターゲットにすることで,細胞バイアスのサイトカインアゴニストの開発が可能になります.
- このアプローチは,より安全で効果的な免疫療法を開発する大きな可能性を秘めています.
関連する概念動画
T Cell Activation and Clonal Selection
14.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.0K
T Cell Types and Functions
1.7K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.7K
Cytotoxic T Cells-mediated Immune Response
6.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.0K
The JAK-STAT Signaling Pathway
10.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10.2K
B Cell Activation and Differentiation
15.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.2K
NF-κB-dependent Signaling Pathway
8.6K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
8.6K

